Current COVID-19 vaccine studies
The UK is a leading force in the development of vaccines for COVID-19. Search our database of studies and trials currently under way.
Filter by:
Project name
Lead Institution
Summary
Funders
Stratification of Clinically Vulnerable People for COVID-19 Risk Using Antibody Testing (STRAVINSKY)
University of Birmingham
This study aims to establish if antibody testing can identify which people remain at greatest risk of severe COVID-19 despite being vaccinated.
Department of Health and Social Care, via the National Institute for Health Research
Usher Institute, The University of Edinburgh
The Vaccine Booster Breakthroughs project (VBB) builds upon the successful, innovative work of the earlier Vaccine Breakthroughs Project.
UK Research and Innovation (as part of the COVID-19 National Core Studies)
Usher Institute, University of Edinburgh
This study’s primary aim is to provide both the UK and the devolved governments (Scotland, Northern Ireland and Wales) with the information necessary to actionably improve COVID-19 vaccine uptake and coverage.
Health Data Research UK
NIHR Manchester Clinical Research Facility
This is the UK arm of a clinical trial of the vaccine (GRT-R910) produced by US-based biotechnology company Gritstone bio, Inc.
Health Innovation Manchester
Usher Institute, University of Edinburgh
Researchers at the University of Edinburgh, in collaboration with Public Health Scotland other partners, are using patient data across Scotland to track the COVID-19 pandemic and its affected across Scotland, as well as monitor the effectiveness o
National Institute for Health Research Health Technology Assessment Programme, Medical Research Council, Scottish Government
Usher Institute, University of Edinburgh
Vaccine breakthrough is a term used to describe the SARS-CoV-2 virus ‘breaking through’ the protection given by COVID-19 vaccines. This includes first-time infections, reinfections and COVID-19 related hospitalisations and deaths.
National Core Studies Immunity Programme, UK Research and Innovation (Medical Research Council), Scottish Government, Health Data Research UK, Chief Scientist Office, National Institute for Health Research
University of Liverpool
A sub-study of the PETReA trial is looking at how effective COVID-19 vaccination is for people with follicular lymphoma.
UK Health Security Agency
The UK Health Security Agency (UKHSA) is undertaking this audit to assess the antibody levels offered by the extended 12-week schedule, compared to a 2 to 3 week interval, and the booster programme in people aged 50 years and over.
University of Exeter
This study will investigate the impact of specific drugs and shielding on COVID-19 infection and subsequent immunity in people with inflammatory bowel disease (IBD).
National Institute for Health Research (NIHR)
University Hospital Southampton NHS Foundation Trust
This study aims to evaluate the robustness and persistence of immune responses to vaccination in people with lymphoid cancers.